Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07120763Phase 3Recruiting
A Phase 3 trial of lidocaine 10% oropharyngeal spray, fentanyl (transdermal patch + oral transmucosal lozenge) in distal radius fracture, sponsored by University at Buffalo. Started Aug 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07120763.